CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 285 filers reported holding CORCEPT THERAPEUTICS INC in Q2 2024. The put-call ratio across all filers is 0.91 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $7,766,897 | +19.3% | 239,055 | -7.5% | 0.01% | +9.1% |
Q1 2024 | $6,509,297 | +119.2% | 258,408 | +182.6% | 0.01% | +83.3% |
Q4 2023 | $2,969,744 | +36.3% | 91,433 | +14.4% | 0.01% | +50.0% |
Q3 2023 | $2,178,102 | +23.1% | 79,945 | +0.5% | 0.00% | 0.0% |
Q2 2023 | $1,769,520 | -3.1% | 79,529 | -5.6% | 0.00% | 0.0% |
Q1 2023 | $1,825,375 | +27.0% | 84,274 | +19.1% | 0.00% | +33.3% |
Q4 2022 | $1,437,684 | -23.2% | 70,787 | -3.0% | 0.00% | -40.0% |
Q3 2022 | $1,871,000 | -13.7% | 72,959 | -20.0% | 0.01% | 0.0% |
Q2 2022 | $2,168,000 | +15.4% | 91,172 | +9.3% | 0.01% | +25.0% |
Q1 2022 | $1,878,000 | +26.3% | 83,384 | +11.0% | 0.00% | +33.3% |
Q4 2021 | $1,487,000 | -19.7% | 75,118 | -20.2% | 0.00% | 0.0% |
Q3 2021 | $1,852,000 | -13.2% | 94,123 | -3.0% | 0.00% | -25.0% |
Q2 2021 | $2,134,000 | -13.0% | 96,998 | -5.9% | 0.00% | 0.0% |
Q1 2021 | $2,453,000 | -35.2% | 103,118 | -28.7% | 0.00% | -42.9% |
Q4 2020 | $3,784,000 | -18.8% | 144,661 | -46.0% | 0.01% | -12.5% |
Q3 2020 | $4,662,000 | -13.5% | 267,827 | -16.4% | 0.01% | -11.1% |
Q2 2020 | $5,387,000 | +49.7% | 320,262 | +5.8% | 0.01% | +50.0% |
Q1 2020 | $3,598,000 | +139.7% | 302,634 | +144.0% | 0.01% | +200.0% |
Q4 2019 | $1,501,000 | -47.4% | 124,037 | -38.5% | 0.00% | -33.3% |
Q3 2019 | $2,851,000 | +27.2% | 201,718 | +0.3% | 0.00% | 0.0% |
Q2 2019 | $2,242,000 | +23.9% | 201,062 | +30.4% | 0.00% | +50.0% |
Q1 2019 | $1,810,000 | +10.4% | 154,188 | +25.7% | 0.00% | 0.0% |
Q4 2018 | $1,639,000 | -51.0% | 122,650 | -48.6% | 0.00% | -33.3% |
Q3 2018 | $3,345,000 | -40.8% | 238,610 | -33.7% | 0.00% | -50.0% |
Q2 2018 | $5,655,000 | -1.1% | 359,725 | +3.4% | 0.01% | 0.0% |
Q1 2018 | $5,720,000 | -55.5% | 347,748 | -51.1% | 0.01% | -53.8% |
Q4 2017 | $12,841,000 | -28.8% | 711,015 | -23.9% | 0.01% | -40.9% |
Q3 2017 | $18,033,000 | +135.3% | 934,384 | +43.8% | 0.02% | +120.0% |
Q2 2017 | $7,665,000 | +94.5% | 649,573 | +80.6% | 0.01% | +100.0% |
Q1 2017 | $3,941,000 | +281.5% | 359,615 | +152.7% | 0.01% | +400.0% |
Q4 2016 | $1,033,000 | +32.4% | 142,292 | +18.6% | 0.00% | 0.0% |
Q3 2016 | $780,000 | +47.4% | 119,979 | +23.9% | 0.00% | 0.0% |
Q2 2016 | $529,000 | -43.7% | 96,804 | -51.8% | 0.00% | -50.0% |
Q1 2016 | $939,000 | -35.2% | 200,733 | -31.0% | 0.00% | -33.3% |
Q4 2015 | $1,448,000 | +132.1% | 290,782 | +75.2% | 0.00% | +200.0% |
Q3 2015 | $624,000 | +87.4% | 165,942 | +199.1% | 0.00% | 0.0% |
Q2 2015 | $333,000 | +41.1% | 55,481 | +31.5% | 0.00% | 0.0% |
Q1 2015 | $236,000 | +26.2% | 42,200 | -32.4% | 0.00% | – |
Q4 2014 | $187,000 | -18.0% | 62,400 | -26.8% | 0.00% | -100.0% |
Q3 2014 | $228,000 | -4.6% | 85,200 | 0.0% | 0.00% | 0.0% |
Q2 2014 | $239,000 | -7.0% | 85,200 | +44.7% | 0.00% | 0.0% |
Q1 2014 | $257,000 | – | 58,900 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
INGALLS & SNYDER LLC | 8,360,485 | $186,021 | 8.91% |
Novo Holdings A/S | 3,377,768 | $75,155,338 | 5.81% |
Parallel Advisors, LLC | 3,726,565 | $82,916,071 | 2.67% |
TANAKA CAPITAL MANAGEMENT INC | 35,539 | $791 | 2.14% |
S&T BANK/PA | 347,260 | $7,727 | 1.39% |
FAS Wealth Partners, Inc. | 310,771 | $6,914,655 | 0.88% |
Birchview Capital, LP | 50,000 | $1,112,500 | 0.83% |
Granite Investment Partners, LLC | 792,519 | $17,633,548 | 0.70% |
Bridge City Capital, LLC | 60,632 | $1,349,062 | 0.64% |
AJ WEALTH STRATEGIES, LLC | 509,934 | $11,346,032 | 0.55% |